Propranolol: A new indication for an old drug in preventing postoperative junctional ectopic tachycardia after surgical repair of tetralogy of Fallot

Interactive Cardiovascular and Thoracic Surgery

Volumn 7, Issue 2, 2008, Pages 184-187

  Mahmoud, Alaa Basiouni S ^a   El Tantawy, Amira ^a   Kouatli, Amjad A ^a   Baslaim, Ghassan M ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Junctional ectopic tachycardia; Propranolol; Tetralogy of Fallot

Indexed keywords

ADRENALIN; AMIODARONE; DIGOXIN; DOBUTAMINE; DOPAMINE; PROPRANOLOL;

ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; FALLOT TETRALOGY; FEMALE; HEART SURGERY; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; JUNCTIONAL ECTOPIC TACHYCARDIA; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TACHYCARDIA;

ANTI-ARRHYTHMIA AGENTS; CARDIAC SURGICAL PROCEDURES; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT; INTENSIVE CARE; LENGTH OF STAY; MALE; PROPRANOLOL; RESEARCH DESIGN; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; TACHYCARDIA, ECTOPIC JUNCTIONAL; TETRALOGY OF FALLOT; TIME FACTORS; TREATMENT OUTCOME;

EID: 41849100695     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2007.160945     Document Type: Article

References (15)

1. Dodge-Khatami A, Miller OI, Anderson RH, Goldman AP, Gil-Jaurena JM, Elliott MJ, Tsang VT, De Leva. Surgical substrates of postoperative junctional ectopic tachycardia in congenital heart defects. J Thorac Cardiovasc Surg 2002;123:624-630.
2. Vignati G, Corato A, Sacerdoti C, Banfi F, Austoni P, Mauri L, Figini A. Immediate and late arrhythmia in patients operated on for tetralogy of Fallot. Pedia Med Chir 1998;20:3-6.
3. Mee RB, Surgical substrates of postoperative junctional ectopic tachycardia. J Thorac Cardiovasc Surg 2002;123:615-616.
4. Walsh E, Saul JP, Sholler GF, Triedman JK, Jonas RA, Mayer JE, Wessel DL. Evaluation of staged treatment protocol for rapid automatic junctional ectopic tachycardia after operation for congenital heart disease. J Am Coll Cardiol 1997;29:1046-1053.
5. Hoffman T, Bush D, Wernovsky G, et al. Postoperative junctional ectopic tachycardia in children: incidence, risk factors, and treatment. Ann Thorac Surg 2002;74:1607-1611.
6. Gillette P. Diagnosis and management of postoperative junctional ectopic tachycardia. Am Heart J 1989;118:192-196.
7. Ponce F, Williams LC, Webb HM, Riopel DA, Hohn AR. Propranolol palliation of tetralogy of Fallot: experience with long-term drug treatment in pediatric patients. Pediatrics 1973;52:100-108.
8. Garson A, Gillette P, McNamara D. Propranolol: the preferred palliation for tetralogy of Fallot. Am J Cardiol 1981;47:1098-1104.
9. Cumming G, Carr W. Hemodynamic effects of propranolol in patients with Fallot's tetralogy. Am Heart J 1967;74:29-36.
10. Villian E, Vetter V, Garcia J, Herre J, Cifarelli A, Garson A. Evolving concepts in the management of congenital junctional tachycardia: a multicenter study. Circulation 1990;81:1544-1549.
11. Yabek S, Berman W, Dillon T. Electrophysiologic effects of propranolol on sinus node function in children. Am Heart J 1982;104:604-612.
12. Carmona M, Malbouisson LM, Pereira VA, Bertoline MA, Omosako CE, Le Bihan KB, Auler Jr JO, Santos SR. Cardiopulmonary bypass alters the pharmacokinetics of propranolol in patients undergoing cardiac surgery. Braz J Med Biol Res 2005;38:713-721.
13. Plachetka J, Salomon N, Copeland J. Plasma propranolol before, during, and after cardiopulmonary bypass. Clin Pharmacol Ther 1981;30;745-751.
14. Wood M, Shand D, Wood A. Propranolol binding in plasma during cardiopulmonary bypass. Anesthesiology 1979;51:512-516.
15. Roth R, Wiersma D. Role of the lung in total body clearance of circulating drugs. Clin Pharmacokinet 1979;4:355-367.